Forbes lists 10 CEOs ‘transforming healthcare in America’

Leaders of advocacy groups, health systems, children’s hospitals and suppliers made the list of 10 CEOs who are “transforming healthcare in America” published by Forbes and The CEO Forum magazine.

Former Cleveland Clinic president and CEO Toby Cosgrove, MD, was among those on the list, saying his system’s initiatives to spur change in the industry have included shifts in hospital design to introducing better, less revealing gowns for patients.

“The organization will continue to innovate and adapt to the changes taking place in healthcare,” he said. “Advancements have changed and will continue to change how we treat patients.”

The full list was:

  • Alan Bauman, MD, founder of restorative hair treatment company Bauman Medical
  • Toby Cosgrove, MD, president and CEO of Cleveland Clinic from 2004-2017
  • Nick Desai, MS, co-founder and CEO of house call app Heal
  • Sandra Fenwick, MPH, president and CEO of Boston Children’s Hospital
  • Graham Gardner, MD, MBA, co-founder and CEO of Kyruus
  • Jo Ann Jenkins, CEO of AARP
  • Kevin Lamb, founder and CEO wound care supplier Advanced Tissue
  • Stephen Klasko, president and CEO of Thomas Jefferson University and Jefferson Health
  • Alan Miller, founder, CEO and chairman of Universal Health Services
  • Ron Williams, CEO of RW2 Enterprises and former CEO of Aetna

Read more at the link below:

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.